Taken together, we believe that CLIC5 gene therapy may be feasible in humans, as hearing loss in these individuals develops postnatally and progresses more gradually than that observed in Clic5−/− mice, potentially offering an expanded window of opportunity for treatment. The gene discussed is CLIC5; the disease is hearing loss disorder.